Research Solutions (RSSS) Cash & Equivalents (2010 - 2026)

Research Solutions (RSSS) has reported Cash & Equivalents for 17 consecutive years, with $12.1 million the latest figure, recorded in Q1 2026.

• On a quarterly basis, Cash & Equivalents rose 22.31% year-over-year to $12.1 million in Q1 2026; TTM through Mar 2026 was $12.1 million, a 22.31% increase from a year earlier, with the FY2025 full-year figure at $12.2 million, up 100.45% from the prior year.
• Cash & Equivalents was $12.1 million for Q1 2026 at Research Solutions, down from $12.3 million in the prior quarter.
• Over five years, Cash & Equivalents peaked at $13.5 million in Q2 2023 and troughed at $2.7 million in Q4 2023.
• A 5-year average of $9.7 million and a median of $10.6 million in 2022 frame the typical range for Cash & Equivalents.
• Across the five-year window, Cash & Equivalents plunged 76.05% in 2023 and surged 185.48% in 2024, its largest moves.
• Over 5 years, Cash & Equivalents stood at $11.3 million in 2022, then sank by 76.05% to $2.7 million in 2023, then surged by 185.48% to $7.7 million in 2024, then jumped by 59.23% to $12.3 million in 2025, then retreated by 1.73% to $12.1 million in 2026.
• The last three Cash & Equivalents figures came in at $12.1 million (Q1 2026), $12.3 million (Q4 2025), and $12.0 million (Q3 2025), per Business Quant data.